Research Methodology on Pharmaceutical Contract Manufacturing Market
1. Introduction
The pharmaceutical contract manufacturing market is predicted to experience rapid growth over the forecast period 2024 to 2032. The purpose of this research report is to analyze and forecast the expected market size in terms of volume and value for pharmaceutical contract manufacturing globally. Pharmaceutical contract manufacturing is a dynamic industry, with recent advances in technology and changing regulations making a major impact. This study aims to provide an in-depth analysis of the current trends and the expected growth in the market over the said forecast period. Additionally, the research also examines the key factors driving and restraining the market.
2. Research Objectives
The main objective of this research is to analyze and forecast the market size of the global pharmaceutical contract manufacturing market up to 2032. Additionally, the research also focuses on the key factors underlying the growth of the market and their market impact.
3. Research Methodology
This research adopts a combination of qualitative and quantitative research methodologies to accurately capture the facets of the market. It uses a comprehensive approach to the analysis which enables the readers to get a better understanding of the industry and draw more accurate conclusions. The research includes a systematic approach to data collection, analysis and validation through various sources.
The primary sources of information for the research include interviews with industry stakeholders including industry experts, key executives, senior management and market players. Additionally, the data gathered from industry reports, market studies, news articles, annual reports and surveys are also utilized in the research. Secondary sources of information used in the research report include market reports from the World Bank, the US Bureau of Economic Analysis, the US Bureau of Labor Statistics, the US Census Bureau, and the World Trade Organization.
A detailed market analysis is carried out to estimate the size of the market and its trends over the forecast period 2024 to 2032. The analysis leverages both primary and secondary sources of information and focuses on the market segments and sub-segments. To differentiate between the different market segments, Porter’s Five Forces Model is used. This model assesses the competitive landscape in the market and identifies the major players in the industry.
The study also includes an estimation of the market size and market share based on historical and current trends. The study examines the factors affecting the market performance in terms of factors such as customer preference and competitive pressures. The research report provides an in-depth analysis of the industry structure and competitive dynamics of the market that will help to identify and profile the major players in the market.
The research uses interactive tools such as SWOT and PESTEL analysis to determine the major industry drivers and constraints in the market. This analysis provides insight into the key market trends and the expected impact of the drivers and restraints on the market over the forecast period.
4. Research Scope
The scope of this research report is to analyze the global pharmaceutical contract manufacturing market. The research report provides an in-depth analysis of the industry structure and competitive dynamics of the market and identifies the major players in the industry. Additionally, the research seeks to provide an in-depth analysis of the expected growth of the market over the forecast period.
5. Market Segmentation
The global pharmaceutical contract manufacturing market is segmented based on drugs, services, and regions.
On the basis of drug type, the market is segmented into active pharmaceutical ingredients (APIs), finished dosage pharmaceutical formulations, and biologics.
Based on services, the market is segmented into facility management, regulatory services, packaging services, production services, and others.
On the basis of region, the market is segmented into North America (U.S. & Canada), Asia Pacific (India, China, Japan, South Korea, and the Rest of Asia Pacific), Europe (Germany, U.K., France, Spain, Italy, and Rest of Europe), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa (GCC and Rest of Middle East & Africa).
6. Conclusion
This research report aims at providing an in-depth analysis of the global pharmaceutical contract manufacturing market and provides an estimated market size and market share of the industry over the forecast period. Additionally, the research report seeks to identify the various factors driving and restraining the growth of the market. Further, the research report also provides an understanding of the industry structure and dynamics and provides an analysis of the key players in the market.
1 Report Prologue
2 Market Introduction
2.1 Scope of the Study 13
2.1.1 Research Objective 13
2.1.2 Assumptions 13
2.1.3 Limitations 14
3 Research Methodology
3.1 Research Process 15
3.2 Primary Research 16
3.3 Secondary Research 16
3.4 Market Size Estimation 16
4 Market Dynamics
4.1 Drivers 19
4.1.1 Patent protection expiration of major drugs and growing demand for generic drugs will boost the growth of CMOs globally (Impact weightage 40%) 19
4.1.2 Competition and economics of production and trade to favour CRO (Impact weightage – 25%) 20
4.1.3 Mutual benefit to both contract manufacturer and client (Impact weightage – 20% ) 21
4.1.4 Lean manufacturing and agility (Impact weightage – 15%) 22
4.2 Restraints 23
4.2.1 Supply Chain Complexity and Issues of Control of 3rd Parties may hamper the market (Impact weightage – 45%) 23
4.2.2 Standardization and interoperability issues ( Impact weightage – 35% ) 24
4.2.3 Growing cost of noncompliance and counterfeited medicines will reduce the market ( Impact weightage -20% ) 25
4.3 Opportunities 26
4.4 Challenges 27
5 Market Factor Analysis
5.1 Porter’s Five Force Analysis 28
5.1.1 Introduction 28
5.1.2 Threat from a New Entrant 29
5.1.3 Bargaining Power of Buyer 30
5.1.4 Bargaining Power of Supplier 31
5.1.5 Threat from substitute 31
5.1.6 Intensity of Competitive Rivalry 32
5.2 Supply Chain Analysis 33
5.2.1 Raw Material 33
5.2.2 Supplier 34
5.2.3 Manufacturer 35
5.2.4 Distributer 35
5.2.5 Customer 36
5.2.6 Consumer 36
6 Global Pharmaceutical Contract Manufacturing Market By Types
6.1 Active Pharmaceutical Ingredient (API) Manufacturing 38
6.2 Finished Dosage Formulation (FDF) Market 38
7 Global Pharmaceutical Contract Manufacturing Market By Regions
7.1 Americas 40
7.1.1 North America 42
7.1.1.1 US 43
7.1.1.2 CANADA 44
7.1.2 SOUTH AMERICA 44
7.2 Europe 46
7.2.1 Western Europe 47
7.2.1.1 Germany 49
7.2.1.2 France 49
7.2.1.3 Italy 50
7.2.1.4 Spain 50
7.2.1.5 UK 51
7.2.1.6 REST OF WESTERN EUROPE 51
7.2.2 Eastern Europe 52
7.3 Asia Pacific 53
7.3.1 China 54
7.3.2 India 55
7.3.3 Japan 55
7.3.4 South Korea 56
7.3.5 Australia 56
7.3.6 Rest of Asia Pacific 57
7.4 Middle East & Africa 58
7.4.1 United Arab Emirates 59
7.4.2 Saudi Arabia 60
7.4.3 Oman 60
7.4.4 Kuwait 61
7.4.5 Qatar 61
7.4.6 Rest of Middle East & Africa 62
8 Company Landscape
9 Company Profile
9.1 Catalant 64
9.1.1 Company Overview 64
9.1.2 Financials 64
9.1.3 Strategy 64
9.1.4 Key Developments 64
9.2 Boehringer Ingelheim 65
9.2.1 Company Overview 65
9.2.2 Financials 65
9.2.3 Key Developments 65
9.3 Lonza AG 66
9.3.1 Company Overview 66
9.3.2 Financials 66
9.3.3 Strategy 66
9.3.4 Key Developments 66
9.4 Grifols International, S.A 67
9.4.1 Company Overview 67
9.4.2 Financials 67
9.5 AbbVie Inc 68
9.5.1 Company Overview 68
9.5.2 Financials 68
9.5.3 Key Developments 68
9.6 Patheon Inc. 69
9.6.1 Company Overview 69
9.6.2 Financials 69
9.6.3 Strategy 69
9.6.4 Key Developments 69
9.7 Vetter 70
9.7.1 Company Overview 70
9.7.2 Financials 70
9.7.3 Strategy 70
9.7.4 Key Developments 70
9.8 Pharmaceutical Product Development 71
9.8.1 Company Overview 71
9.8.2 Financials 71
9.8.3 Key Developments 71
10 Conclusion 72
10.1 Key Findings 72
10.1.1 From CEO’s View Point 72
10.1.2 Unmet Needs 73
10.1.3 Prediction of pharmaceutical contract manufacturing Industry 73
10 Appendix
11.1 Discussion Blue Print 74
11 List of Tables
TABLE 1 GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY TYPES US$ MILLION (2020-2027) 37
TABLE 2 GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET FOR ACTIVE PHARMACEUTICAL INGREDIENT (API) MANUFACTURING US$ MILLION (2020-2027) 38
TABLE 3 GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET FOR FINISHED DOSAGE FORMULATION (FDF) US$ MILLION (2020-2027) 38
TABLE 4 GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY REGIONS US$ MILLION (2020-2027) 39
TABLE 5 AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY REGIONS US$ MILLION (2020-2027)+ 40
TABLE 6 AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY TYPES US$ MILLION (2020-2027) 41
TABLE 7 NORTH AMERICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY REGIONS US$ MILLION (2020-2027) 42
TABLE 8 NORTH AMERICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY TYPES US$ MILLION (2020-2027) 43
TABLE 9 US PHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY TYPES US$ MILLION (2020-2027) 43
TABLE 10 CANADA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY TYPES US$ MILLION (2020-2027) 44
TABLE 11 SOUTH AMERICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY TYPES US$ MILLION (2020-2027) 44
TABLE 12 EUROPE PHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY REGIONS US$ MILLION (2020-2027) 46
TABLE 13 EUROPE PHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY TYPES US$ MILLION (2020-2027) 47
TABLE 14 WESTERN EUROPE PHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY REGIONS US$ MILLION (2020-2027) 47
TABLE 15 WESTERN EUROPE PHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY TYPES US$ MILLION (2020-2027) 48
TABLE 16 GERMANY PHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY TYPES US$ MILLION (2020-2027) 49
TABLE 17 FRANCE PHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY TYPES US$ MILLION (2020-2027) 49
TABLE 18 ITALY PHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY TYPES US$ MILLION (2020-2027) 50
TABLE 19 SPAIN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY TYPES US$ MILLION (2020-2027) 50
TABLE 20 UK PHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY TYPES US$ MILLION (2020-2027) 51
TABLE 21 REST OF WESTERN EUROPE PHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY TYPES US$ MILLION (2020-2027) 51
TABLE 22 EASTERN EUROPE PHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY TYPES US$ MILLION (2020-2027) 52
TABLE 23 ASIA PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY REGIONS US$ MILLION (2020-2027) 53
TABLE 24 ASIA PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY TYPES US$ MILLION (2020-2027) 54
TABLE 25 CHINA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY TYPES US$ MILLION (2020-2027) 54
TABLE 26 INDIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY TYPES US$ MILLION (2020-2027) 55
TABLE 27 JAPAN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY TYPES US$ MILLION (2020-2027) 55
TABLE 28 SOUTH KOREA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY TYPES US$ MILLION (2020-2027) 56
TABLE 29 AUSTRALIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY TYPES US$ MILLION (2020-2027) 56
TABLE 30 REST OF ASIA PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY TYPES US$ MILLION (2020-2027) 57
TABLE 31 MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY REGIONS US$ MILLION (2020-2027) 58
TABLE 32 MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY TYPES US$ MILLION (2020-2027) 59
TABLE 33 UNITED ARAB EMIRATES PHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY TYPES US$ MILLION (2020-2027) 59
TABLE 34 SAUDI ARABIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY TYPES US$ MILLION (2020-2027) 60
TABLE 35 OMAN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY TYPES US$ MILLION (2020-2027) 60
TABLE 36 KUWAIT PHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY TYPES US$ MILLION (2020-2027) 61
TABLE 37 QATAR PHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY TYPES US$ MILLION (2020-2027) 61
TABLE 38 REST OF MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY TYPES US$ MILLION (2020-2027) 62
TABLE 39 GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SHARE ANALYSIS 2020 (%) 63
12 List of Figures
FIGURE 1 GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY TYPES MARKET SHARE 2020(%) 11
FIGURE 2 GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY REGIONS MARKET SHARE 2020(%) 12
FIGURE 3 MARKET STRUCTURE 14
FIGURE 4 RESEARCH PROCESS 15
FIGURE 5 GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET: PORTER FIVE FORCES ANALYSIS 29
FIGURE 6 GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY TYPES US$ MILLION 2020 & 2027 37
FIGURE 7 GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY REGIONS US$ MILLION 2020 & 2027 39
FIGURE 8 AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY REGIONS MARKET SHARE 2020 (%) 40
FIGURE 9 NORTH AMERICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY COUNTRY MARKET SHARE 2020 (%) 42
FIGURE 10 EUROPE PHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY REGIONS MARKET SHARE 2020 (%) 46
FIGURE 11 WESTERN EUROPE PHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY COUNTRY MARKET SHARE 2020 (%) 48
FIGURE 12 ASIA PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY REGIONS MARKET SHARE 2020 (%) 53
FIGURE 13 MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY REGIONS MARKET SHARE 2020 (%) 58
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
